E-mail a Wiley Online Library Link

Georgia M. Beasley, Ketan Sharma, Joyce Wong, Mike Miller, Ryan S. Turley, Michael Lidsky, Melanie Masoud, Mark W. Dewhirst, Paul J. Mosca, Jonathan S. Zager and Douglas S. Tyler A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion Cancer 118

Version of Record online: 6 JUN 2012 | DOI: 10.1002/cncr.27676

Although studies of melphalan-based isolated limb infusion (ILI) combine data from upper extremity treatments with data from lower extremity treatments, differences between the 2 may be clinically important. The upper extremity appears to be relatively resistant to the toxic effects of melphalan-based ILI as it is currently performed, suggesting a potential for further optimization of drug dosing for upper extremity ILI.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field